Literature DB >> 21861211

New strategies in neuroprotection and neurorepair.

Marta C Antonelli1, Gilles J Guillemin, Rita Raisman-Vozari, Elaine A Del-Bel, Michael Aschner, Michael A Collins, Yousef Tizabi, Rosario Moratalla, Adrian K West.   

Abstract

There are currently few clinical strategies in place, which provide effective neuroprotection and repair, despite an intense international effort over the past decades. One possible explanation for this is that a deeper understanding is required of how endogenous mechanisms act to confer neuroprotection. This mini-review reports the proceedings of a recent workshop "Neuroprotection and Neurorepair: New Strategies" (Iguazu Falls, Misiones, Argentina, April 11-13, 2011, Satellite Symposium of the V Neurotoxicity Society Meeting, 2011) in which four areas of active research were identified to have the potential to generate new insights into this field. Topics discussed were (i) metallothionein and other multipotent neuroprotective molecules; (ii) oxidative stress and their signal mediated pathways in neuroregeneration; (iii) neurotoxins in glial cells, and (iv) drugs of abuse with neuroprotective effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861211      PMCID: PMC3243800          DOI: 10.1007/s12640-011-9265-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  49 in total

1.  Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

Authors:  Cristina Blázquez; Anna Chiarlone; Onintza Sagredo; Tania Aguado; M Ruth Pazos; Eva Resel; Javier Palazuelos; Boris Julien; María Salazar; Christine Börner; Cristina Benito; Carolina Carrasco; María Diez-Zaera; Paola Paoletti; Miguel Díaz-Hernández; Carolina Ruiz; Michael Sendtner; José J Lucas; Justo G de Yébenes; Giovanni Marsicano; Krisztina Monory; Beat Lutz; Julián Romero; Jordi Alberch; Silvia Ginés; Jürgen Kraus; Javier Fernández-Ruiz; Ismael Galve-Roperh; Manuel Guzmán
Journal:  Brain       Date:  2010-10-07       Impact factor: 13.501

2.  Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways.

Authors:  Y K J Leung; M Pankhurst; S A Dunlop; S Ray; J Dittmann; E D Eaton; P Palumaa; R Sillard; M I Chuah; A K West; R S Chung
Journal:  Exp Neurol       Date:  2009-10-15       Impact factor: 5.330

Review 3.  Roles of the metallothionein family of proteins in the central nervous system.

Authors:  J Hidalgo; M Aschner; P Zatta; M Vasák
Journal:  Brain Res Bull       Date:  2001-05-15       Impact factor: 4.077

4.  Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Authors:  D T Dexter; C J Carter; F R Wells; F Javoy-Agid; Y Agid; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

Review 5.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

6.  Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

Authors:  Noelia Granado; Sara Ares-Santos; Idaira Oliva; Esther O'Shea; Eduardo D Martin; M Isabel Colado; Rosario Moratalla
Journal:  Neurobiol Dis       Date:  2011-02-15       Impact factor: 5.996

7.  Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family.

Authors:  Malene Ambjørn; Johanne W Asmussen; Mats Lindstam; Kamil Gotfryd; Christian Jacobsen; Vladislav V Kiselyov; Søren K Moestrup; Milena Penkowa; Elisabeth Bock; Vladimir Berezin
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

8.  Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro.

Authors:  Robert M Mitchell; Edward J Neafsey; Michael A Collins
Journal:  J Neurochem       Date:  2009-08-19       Impact factor: 5.372

9.  Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain.

Authors:  T Storck; S Schulte; K Hofmann; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 10.  Alcohol, dementia and cognitive decline in the elderly: a systematic review.

Authors:  Ruth Peters; Jean Peters; James Warner; Nigel Beckett; Christopher Bulpitt
Journal:  Age Ageing       Date:  2008-05-16       Impact factor: 10.668

View more
  6 in total

1.  Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress.

Authors:  E Fabian; D Reglodi; L Mester; A Szabo; K Szabadfi; A Tamas; G Toth; K Kovacs
Journal:  J Mol Neurosci       Date:  2012-05-29       Impact factor: 3.444

2.  D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice.

Authors:  N Granado; S Ares-Santos; R Moratalla
Journal:  Neurotox Res       Date:  2013-11-21       Impact factor: 3.911

3.  Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.

Authors:  Yousef Tizabi; Bruk Getachew
Journal:  Clin Pharmacol Transl Med       Date:  2017-03-06

Review 4.  Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review.

Authors:  Cristoforo Pomara; Margherita Neri; Stefania Bello; Carmela Fiore; Irene Riezzo; Emanuela Turillazzi
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

5.  MLIF Alleviates SH-SY5Y Neuroblastoma Injury Induced by Oxygen-Glucose Deprivation by Targeting Eukaryotic Translation Elongation Factor 1A2.

Authors:  Qiuzhen Zhu; Yuefan Zhang; Yulan Liu; Hao Cheng; Jing Wang; Yue Zhang; Yaocheng Rui; Tiejun Li
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

6.  4-Hydroxy-3,5-di-tret-butyl cinnamic acid restores the activity of the hippocampal mitochondria in rats under permanent focal cerebral ischemia.

Authors:  Dmitry I Pozdnyakov
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.